BPCL Q4 net profit slides 8% to ₹4,392 crore


BPCL registered a gross refining margin of $9.20/bbl during the quarter against $5.60/bbl in the previous quarter

BPCL registered a gross refining margin of $9.20/bbl during the quarter against $5.60/bbl in the previous quarter

Bharat Petroleum Corporation Ltd. (BPCL), for the fourth quarter ended March 31, 2025, reported an 8% fall in consolidated net profit attributed to the owners of the company to ₹4,392 crore from ₹4,790 crore in the year-ago period.

The company’s revenue for the quarter declined 4% to ₹1,26,916 crore year on year (YoY). The board has recommended a dividend of ₹5 per share with a face value of ₹10 each.

For FY25, the company’s net profit plunged to ₹13,337 crore from ₹26,859 crore in the previous year, down 50%. 

Annual sales revenue also fell slightly above 1% to ₹5,00,517 crore from ₹5,06,993 crore in the previous year.

On a standalone basis, BPCL has recorded an annual net profit of ₹13,275 crore as compared with a net profit of ₹26,673.50 crore in the previous year.

The net profit for the fourth quarter stood at ₹3,214.06 crore as compared with a net profit of ₹4,224 crore a year earlier.

The quarterly performance was driven by improved refining and marketing margins, strong sales growth, and operational excellence, the company said.

BPCL registered a Gross Refining Margin (GRM) of $9.20/bbl during the quarter against a GRM of $5.60/bbl in the previous quarter.

In the financial year, BPCL said it achieved throughput of 40.51 MMT vs. 39.93 MMT in FY24.

During the year, it achieved market sales of 52.40 MMT vs. 51.04 MMT in FY 24, up 2.66%.

During the quarter, It achieved throughput of 10.58 MMT against 10.36 MMT in the year-earlier period. The market sales for the period increased to 13.42 MMT from 13.18 MMT in the same period last year, up 1.82%.



Source link

  • Related Posts

    Lupin, China’s SUP ink pact for COPD drug Tiotropium DPI

    Lupin has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP) for commercialisation of chronic obstructive pulmonary disease drug Tiotropium Dry Powder Inhaler, 18 mcg/capsule, in the Chinese…

    Continue reading
    India to export 150 locomotives to Africa worth over ₹3,000 crore

    “These locomotives are fitted with Distributed Power Wireless Control System, or DPWCS, for synchronised operations and superior freight handling,” a Railways Ministry spokesperson said. Photo: https://www.wabteccorp.com/ India will supply 150…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *